SCUPOLI, Maria
 Distribuzione geografica
Continente #
NA - Nord America 7.024
EU - Europa 5.932
AS - Asia 4.179
SA - Sud America 466
AF - Africa 37
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 17.673
Nazione #
US - Stati Uniti d'America 6.933
GB - Regno Unito 2.104
CN - Cina 1.767
SG - Singapore 1.430
IT - Italia 716
DE - Germania 645
SE - Svezia 524
FR - Francia 473
HK - Hong Kong 406
IE - Irlanda 405
BR - Brasile 401
RU - Federazione Russa 352
FI - Finlandia 342
VN - Vietnam 119
KR - Corea 109
UA - Ucraina 98
JP - Giappone 95
BE - Belgio 65
CA - Canada 60
NL - Olanda 53
TR - Turchia 52
IN - India 47
AT - Austria 31
ID - Indonesia 31
ES - Italia 26
IR - Iran 22
AR - Argentina 21
PL - Polonia 21
AU - Australia 20
BD - Bangladesh 19
MX - Messico 19
IQ - Iraq 13
ZA - Sudafrica 11
CH - Svizzera 10
UZ - Uzbekistan 9
CO - Colombia 8
EC - Ecuador 8
LT - Lituania 8
RO - Romania 8
VE - Venezuela 8
CL - Cile 7
IL - Israele 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
DK - Danimarca 6
HU - Ungheria 6
KZ - Kazakistan 6
PK - Pakistan 6
PY - Paraguay 6
TG - Togo 6
MA - Marocco 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
EU - Europa 4
JO - Giordania 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
OM - Oman 3
PE - Perù 3
SA - Arabia Saudita 3
SN - Senegal 3
AM - Armenia 2
AO - Angola 2
BY - Bielorussia 2
DZ - Algeria 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
LU - Lussemburgo 2
MY - Malesia 2
NC - Nuova Caledonia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
IS - Islanda 1
LI - Liechtenstein 1
MK - Macedonia 1
ML - Mali 1
Totale 17.664
Città #
Southend 1.895
Chandler 922
Jacksonville 739
Dallas 718
Singapore 662
Woodbridge 629
Ann Arbor 482
Ashburn 478
Dublin 401
Hong Kong 401
Beijing 328
Verona 315
New York 247
Houston 242
Jinan 163
Munich 163
Wilmington 163
Lawrence 136
Princeton 136
Nanjing 130
Shenyang 122
The Dalles 110
Hebei 78
Helsinki 76
Columbus 70
Tianjin 67
Changsha 66
Turku 65
Brussels 63
Los Angeles 62
Ningbo 60
Redmond 56
Zhengzhou 56
Phoenix 54
Haikou 53
Milan 47
Hangzhou 46
Nanchang 43
Boardman 41
Guangzhou 40
Buffalo 39
São Paulo 38
Santa Clara 37
Seoul 37
Taiyuan 36
Dong Ket 34
Jiaxing 33
Council Bluffs 31
Taizhou 31
Dearborn 30
Jakarta 27
Kent 26
Sindelfingen 26
Tokyo 26
Düsseldorf 24
Frankfurt am Main 24
Fuzhou 24
Falls Church 23
Norwalk 23
Washington 23
Lancaster 22
Redondo Beach 22
San Francisco 20
Chicago 19
Ho Chi Minh City 19
Toronto 19
Vienna 19
Boston 18
Brooklyn 18
Seattle 18
Bologna 17
Lanzhou 17
Manchester 17
Moscow 17
Padova 16
Fairfield 15
London 15
Nürnberg 15
Montreal 14
Redwood City 14
Warsaw 14
Stockholm 13
Zanjan 12
Hanoi 11
Rio de Janeiro 11
Auburn Hills 10
Belo Horizonte 10
Brescia 10
Nuremberg 10
San Mateo 10
Sydney 10
Venice 10
Chennai 9
Curitiba 9
Denver 9
Fremont 9
Kochi 9
Ottawa 9
Rome 9
Brasília 8
Totale 11.770
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 389
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 263
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 189
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 186
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 183
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 183
Ascorbic Acid Induces either Differentiation or Apoptosis in MG-63 Osteosarcoma Lineage 183
Runx2 downregulation, migration and proliferation inhibition in melanoma cells treated with BEL β-trefoil 180
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 179
CRISPR/Cas9 as a tool for studying the interactions between viral and cellular proteins 179
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 174
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 172
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 167
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 166
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 164
Metodi in vitro di diagnosi, prognosi e trattamento di disordini ematopoietici 162
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 160
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 160
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 158
APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis. 156
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 156
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 155
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 154
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 153
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 153
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 152
Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells 152
BCR-signaling profiles associated with prognosis and progression in B-CLL 151
ANTI-INFLAMMATORY EFFECT OF MIGLUSTAT: SPHINGOLIPID METABOLISM AS A THERAPEUTIC TARGET FOR CF LUNG INFLAMMATION 151
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 148
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 147
A quantitative study on the growth variability of tumour cell clones in vitro 146
BCR-signaling profiles associated with prognosis and progression in B-CLL 146
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 142
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 142
Pharmacological modulators of sphingolipid metabolism for the treatment of cystic fibrosis lung inflammation 142
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 141
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 141
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 141
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 141
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity 140
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 139
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 139
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 138
Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity 138
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 133
HTLV type IIIB infection of human thymic epithelial cells: viral expression correlates with the induction of NF-kappa B-binding activity in cells activated by cell adhesion. 132
Underdiagnosed systemic mastocytosis: The role of flow cytometry 132
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 132
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 131
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 129
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 128
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells 128
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 126
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 126
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 126
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 126
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 125
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 124
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 124
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 124
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 123
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 123
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 122
Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. 121
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 120
Neurodegeneration-associated proteins in human olfactory neurons collected by nasal brushing 120
Thymocyte contact or monoclonal antibody-mediated clustering of 3beta1 or 6beta4 integrins activate interleukin-6 (IL-6) transcription factors (NF-kappaB and NF-IL6) and IL-6 production in human thymic epithelial cells. 119
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 118
DOWN-MODULATION OF NEUTROPHIL CHEMOTACTIC SIGNALLING BY TARGETING THE METABOLISM OF SPHINGOLIPIDS 118
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression. 117
Mesenchymal Stromal Cells interplay with Umbilical Cord Blood Hematopoietic Progenitor Cells for hematopoietic reconstitution. Co-culturing effects and Gene Expression Profiles 117
Lymphoid adhesion promotes human thymic epithelial cell survival via NF-(kappa)B activation. 116
Interspecies somatic T cell hybrids as biological tools for studying gene expression during T cell development. 116
Serum- and stroma-free in vitro culture of primary B-CLL cells 116
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 116
Thymic epithelial cell-derived interleukin-7 promotes survival of human T-cell acute lymphoblastic leukemia 116
Regulation of catalase expression in chronic lymphocytic leukemia cells. 116
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 116
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 114
Modulators of Sphingolipid Metabolism Reduce Lung Inflammation 114
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 114
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 114
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. 113
Effect of interleukin-12 on the cytokine profile of human CD4 and CD8 T-cell clones. 113
Cancer of Vater's ampulla: molecular pathogenesis and prognosis 113
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV 113
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 112
CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. 111
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 111
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 111
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. 110
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 110
Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer 110
Regenerative potential of the Bichat fat pad determined by the quantification of multilineage differentiating stress enduring cells 109
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 108
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 108
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 107
BCR Responsiveness is associated with Time to First Treatment (TTFT) in B-Cell Chronic Lymphocytic Leukemia (B-CLL): results from a Single Cell Network Profiling (SCNP) verification study 107
Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia 106
Totale 13.905
Categoria #
all - tutte 59.937
article - articoli 34.567
book - libri 0
conference - conferenze 24.467
curatela - curatele 0
other - altro 137
patent - brevetti 362
selected - selezionate 0
volume - volumi 404
Totale 119.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.062 0 0 88 168 155 166 29 76 58 12 203 107
2021/20221.406 156 425 9 100 67 30 43 78 52 50 120 276
2022/20232.722 171 317 213 510 251 634 19 158 302 59 64 24
2023/20241.520 60 83 112 116 184 401 98 83 17 65 203 98
2024/20253.479 159 206 116 579 173 144 179 177 564 225 346 611
2025/20261.932 743 607 582 0 0 0 0 0 0 0 0 0
Totale 17.879